<?xml version="1.0" encoding="UTF-8"?>
<p id="p0400">Sekowski et al reported the high chances of Posttraumatic Stress Disorder (PTSD) in COVID-19 survivors based on previous research on PTSD in epidemic survivors (e.g. SARS)[
 <xref rid="bb0715" ref-type="bibr">143</xref>]. PTSD is a serious mental disorder that negatively affects functioning and social life by reliving the traumatic event, emotional numbness and increased arousal. Preliminary report by Bo et al indicated that almost all clinically stable patients with COVID-19 in China experienced significant severity of post-traumatic stress symptoms [
 <xref rid="bb0720" ref-type="bibr">144</xref>]. Both the studies suggest to regularly screen for PTSD and pay attention on individuals at increased risk of complications, appropriate crisis psychological interventions and long-term follow up assessments should be started immediately for COVID-19 survivors. The issue of negative detrimental impact of significant posttraumatic stress prevalence of PTSD in individuals post COVID-19 remains a matter of future research as symptoms may develop up to 6Â months after the traumatic event [
 <xref rid="bb0715" ref-type="bibr">143</xref>].
</p>
